Regeneron pharmaceuticals, inc. sued for securities law violations – investors should contact levi & korsinsky for more information – regn

New york, feb. 21, 2025 (globe newswire) -- levi & korsinsky, llp notifies investors in regeneron pharmaceuticals, inc. ("regeneron" or the "company") (nasdaq: regn) of a class action securities lawsuit.

REGN Ratings Summary

REGN Quant Ranking